General Information of the Compound
Compound ID
CP0887584
Compound Name
4-((2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrimidin-3-yl)methyl)morpholine
    Show/Hide
Structure
Formula
C23H21ClN4O
Molecular Weight
404.901
Canonical SMILES
Clc1ccc(-c2nc3ncc(-c4ccccc4)cn3c2CN2CCOCC2)cc1
    Show/Hide
InChI
InChI=1S/C23H21ClN4O/c24-20-8-6-18(7-9-20)22-21(16-27-10-12-29-13-11-27)28-15-19(14-25-23(28)26-22)17-4-2-1-3-5-17/h1-9,14-15H,10-13,16H2
    Show/Hide
InChIKey
HTRJRUGTKNKJAW-UHFFFAOYSA-N
Physicochemical Property
logP
4.5489
Rotatable Bonds
4
Heavy Atom Count
29
Polar Areas
42.66
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Complexity
29

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 121309635
ChEMBL ID
CHEMBL4281475
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04657, Solute carrier family 2, facilitated glucose transporter member 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS